Nexalin Technology (NXL) EBITDA Margin (2021 - 2026)
Nexalin Technology has reported EBITDA Margin over the past 5 years, most recently at 1381.95% for Q4 2025.
- For Q4 2025, EBITDA Margin rose 904324.0% year-over-year to 1381.95%; the TTM value through Dec 2025 reached 2725.46%, up 178334.0%, while the annual FY2025 figure was 2725.46%, 178334.0% up from the prior year.
- EBITDA Margin for Q4 2025 was 1381.95% at Nexalin Technology, up from 12550.4% in the prior quarter.
- Over five years, EBITDA Margin peaked at 24.83% in Q3 2022 and troughed at 12550.4% in Q3 2025.
- A 5-year average of 3896.79% and a median of 2371.44% in 2021 define the central range for EBITDA Margin.
- Biggest five-year swings in EBITDA Margin: plummeted -963584bps in 2023 and later surged 904324bps in 2025.
- Year by year, EBITDA Margin stood at 2406.3% in 2021, then grew by 25bps to 1804.51% in 2022, then tumbled by -111bps to 3807.33% in 2023, then crashed by -174bps to 10425.19% in 2024, then soared by 87bps to 1381.95% in 2025.
- Business Quant data shows EBITDA Margin for NXL at 1381.95% in Q4 2025, 12550.4% in Q3 2025, and 2239.01% in Q2 2025.